Prevention of aspirin-induced faecal blood loss by prostaglandin E2. - Wikidata - awgldk - TriplyDB

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

http://www.wikidata.org/entity/Q34495612

about

Effects of prostaglandin E2 on disease activity, gastric secretion and intestinal permeability, and morphology in patients with rheumatoid arthritis.Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.Prostaglandins and the protection of the gastroduodenal mucosa in humans: a critical review.Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.

P2860

Q33570123-7E1A93C4-84B3-4871-AFEE-A52CD6A1980B Q38627221-74E5D32E-D8D0-4D2E-B4BA-CC8E8C352E94 Q39837520-8910F262-4EBA-486B-A9AA-CDAD710F1C08 Q41894322-B190FE14-2F4E-410A-BC7E-15B7618E8E98

P2860

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

http://www.wikidata.org/entity/Q34495612

description

1980 nî lūn-bûn

@nan

1980 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1980 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1980年の論文

@ja

1980年論文

@yue

1980年論文

@zh-hant

1980年論文

@zh-hk

1980年論文

@zh-mo

1980年論文

@zh-tw

1980年论文

@wuu

name

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@ast

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@en

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@nl

type

label

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@ast

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@en

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@nl

prefLabel

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@ast

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@en

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@nl

P1433

Q34495612-05864464-667E-4542-ADEC-2EB83D16660F

P1476

Q34495612-48BE9FD4-7BB7-437C-8D6F-8112C5D6C635

P2093

Q34495612-21D3953F-3DCA-4408-B412-1AB7A2F1C97D

Q34495612-26452393-82AE-4E8E-AA1B-8B5A28EC94EA

Q34495612-E8C096DD-EF98-49C1-A376-4541CE1293A1

P2860

Q34495612-39A4F8CC-EC29-4D4E-B2B0-4CA74E717336

Q34495612-3D08A939-F701-4615-8732-B85F3617C806

Q34495612-4913E327-6E4B-4ADC-B755-76D38113501D

Q34495612-50DEFA34-BEB8-4C2E-B6C1-295EAD1FA7A3

Q34495612-52DE2AC8-09FF-4653-8FBF-218877264436

Q34495612-58854157-1A15-479F-B6F3-E1BF98355040

Q34495612-5A6B50EC-287D-4A6D-8AA6-1BA7EBF2E041

Q34495612-65EF0B1D-23C0-4A7B-A582-71B7E53AEFF5

Q34495612-6E7BDA4F-D1E2-46F4-AE0E-F2550E9DDD38

Q34495612-94ABB2F0-A1F1-484A-849E-49EADDFA71E4

P304

Q34495612-0D8046D5-0BB5-48F4-9A8B-9D4AB752F295

P31

Q34495612-BD3BBE2B-869E-496A-A7F0-601A49A1D373

P356

Q34495612-C184246A-4D29-40DE-8CF3-743E8CD7E52D

P407

Q34495612-9F3FCC08-32ED-4200-B7FC-35D230CD7D12

P433

Q34495612-7338F46C-E9BE-473C-82E3-E738FCCA8FBC

P478

Q34495612-9848B438-B40B-4D1E-9AD3-D6DCC2D3CCE6

P577

Q34495612-4F51A501-6EA6-4862-B6F3-45427EDB5564

P5875

Q34495612-EEFA20F9-F885-4F89-9884-9A9B161413CA

P698

Q34495612-70525178-0328-47AF-90EA-A203963F30E8

P921

Q34495612-3327DD60-4406-4E70-86F9-81CB3AE83DE3

Q34495612-EF82E03B-86AB-4D35-95FA-C853202A1082

P932

Q34495612-A016D74F-1356-418A-8DDD-F4F905BBEBB3

P356

P1433

P1476

Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

@en

P2093

Cheung G

http://www.w3.org/2001/XMLSchema#string

Cohen MM

http://www.w3.org/2001/XMLSchema#string

Lyster DM

http://www.w3.org/2001/XMLSchema#string

P2860

Fecal blood loss produced by oral and intravenous administration of various salicylates

Effect of 16,16-dimethyl prostaglandin E2 on the gastric mucosal barrier.

Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.

The effects E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat.

Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.

Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.

Aspirin intolerance--a review.

Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings]

Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers.

Stimulation of alkaline secretion in amphibian-isolated gastric mucosa by 16,16-dimethyl PGE2 and PGF2 alpha. A proposed explanation for some of the cytoprotective actions of prostaglandins.

P304

602-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.21.7.602

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

1980-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16197671

http://www.w3.org/2001/XMLSchema#string

P698

7000631

http://www.w3.org/2001/XMLSchema#string

P921

P932

1419893

http://www.w3.org/2001/XMLSchema#string